BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22199996)

  • 21. MAPK genes interact with diet and lifestyle factors to alter risk of breast cancer: the Breast Cancer Health Disparities Study.
    Slattery ML; Lundgreen A; John EM; Torres-Mejia G; Hines L; Giuliano AR; Baumgartner KB; Stern MC; Wolff RK
    Nutr Cancer; 2015; 67(2):292-304. PubMed ID: 25629224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of stress-activated protein kinase/c-Jun N-terminal kinase, but not NF-kappaB, by the tumor necrosis factor (TNF) receptor 1 through a TNF receptor-associated factor 2- and germinal center kinase related-dependent pathway.
    Shi CS; Kehrl JH
    J Biol Chem; 1997 Dec; 272(51):32102-7. PubMed ID: 9405407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1.
    Slattery ML; Herrick JS; Lundgreen A; Fitzpatrick FA; Curtin K; Wolff RK
    Carcinogenesis; 2010 Sep; 31(9):1604-11. PubMed ID: 20622004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations between genetic variation in RUNX1, RUNX2, RUNX3, MAPK1 and eIF4E and riskof colon and rectal cancer: additional support for a TGF-β-signaling pathway.
    Slattery ML; Lundgreen A; Herrick JS; Caan BJ; Potter JD; Wolff RK
    Carcinogenesis; 2011 Mar; 32(3):318-26. PubMed ID: 21088106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TNF-mediated activation of the stress-activated protein kinase pathway: TNF receptor-associated factor 2 recruits and activates germinal center kinase related.
    Shi CS; Leonardi A; Kyriakis J; Siebenlist U; Kehrl JH
    J Immunol; 1999 Sep; 163(6):3279-85. PubMed ID: 10477597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic variation in bone morphogenetic protein and colon and rectal cancer.
    Slattery ML; Lundgreen A; Herrick JS; Kadlubar S; Caan BJ; Potter JD; Wolff RK
    Int J Cancer; 2012 Feb; 130(3):653-64. PubMed ID: 21387313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor necrosis factor (TNF)-induced germinal center kinase-related (GCKR) and stress-activated protein kinase (SAPK) activation depends upon the E2/E3 complex Ubc13-Uev1A/TNF receptor-associated factor 2 (TRAF2).
    Shi CS; Kehrl JH
    J Biol Chem; 2003 Apr; 278(17):15429-34. PubMed ID: 12591926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor necrosis factor alpha-induced activation of c-jun N-terminal kinase is mediated by TRAF2.
    Reinhard C; Shamoon B; Shyamala V; Williams LT
    EMBO J; 1997 Mar; 16(5):1080-92. PubMed ID: 9118946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bridging the NFAT and NF-kappaB families: NFAT5 dimerization regulates cytokine gene transcription in response to osmotic stress.
    López-Rodríguez C; Aramburu J; Jin L; Rakeman AS; Michino M; Rao A
    Immunity; 2001 Jul; 15(1):47-58. PubMed ID: 11485737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The tumor necrosis factor receptor superfamily member 1B polymorphisms predict response to anti-TNF therapy in patients with autoimmune disease: A meta-analysis.
    Chen W; Xu H; Wang X; Gu J; Xiong H; Shi Y
    Int Immunopharmacol; 2015 Sep; 28(1):146-53. PubMed ID: 26071216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Src kinase pathway is involved in NFAT5-mediated S100A4 induction by hyperosmotic stress in colon cancer cells.
    Chen M; Sastry SK; O'Connor KL
    Am J Physiol Cell Physiol; 2011 May; 300(5):C1155-63. PubMed ID: 21289293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic variation in the transforming growth factor-β signaling pathway and survival after diagnosis with colon and rectal cancer.
    Slattery ML; Lundgreen A; Herrick JS; Wolff RK; Caan BJ
    Cancer; 2011 Sep; 117(18):4175-83. PubMed ID: 21365634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2.
    Eliopoulos AG; Blake SM; Floettmann JE; Rowe M; Young LS
    J Virol; 1999 Feb; 73(2):1023-35. PubMed ID: 9882303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NFAM1, an immunoreceptor tyrosine-based activation motif-bearing molecule that regulates B cell development and signaling.
    Ohtsuka M; Arase H; Takeuchi A; Yamasaki S; Shiina R; Suenaga T; Sakurai D; Yokosuka T; Arase N; Iwashima M; Kitamura T; Moriya H; Saito T
    Proc Natl Acad Sci U S A; 2004 May; 101(21):8126-31. PubMed ID: 15143214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brefeldin A-Inhibited Guanine Nucleotide-Exchange Factor 1 (BIG1) Governs the Recruitment of Tumor Necrosis Factor Receptor-Associated Factor 2 (TRAF2) to Tumor Necrosis Factor Receptor 1 (TNFR1) Signaling Complexes.
    Noguchi T; Tsuchida M; Kogue Y; Spadini C; Hirata Y; Matsuzawa A
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations between smoking, passive smoking, GSTM-1, NAT2, and rectal cancer.
    Slattery ML; Edwards S; Curtin K; Schaffer D; Neuhausen S
    Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):882-9. PubMed ID: 14504199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TRAF2 plays a key, nonredundant role in LIGHT-lymphotoxin beta receptor signaling.
    Kim YS; Nedospasov SA; Liu ZG
    Mol Cell Biol; 2005 Mar; 25(6):2130-7. PubMed ID: 15743811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic Variation on
    Yue M; Huang P; Wang C; Fan H; Tian T; Wu J; Luo F; Fu Z; Xia X; Zhu P; Li J; Han Y; Zhang Y; Hou W
    Immunol Invest; 2021 Jan; 50(1):1-11. PubMed ID: 31928491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutant forms of tumour necrosis factor receptor I that occur in TNF-receptor-associated periodic syndrome retain signalling functions but show abnormal behaviour.
    Todd I; Radford PM; Draper-Morgan KA; McIntosh R; Bainbridge S; Dickinson P; Jamhawi L; Sansaridis M; Huggins ML; Tighe PJ; Powell RJ
    Immunology; 2004 Sep; 113(1):65-79. PubMed ID: 15312137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modeling of tumor necrosis factor receptor superfamily 1A mutants associated with tumor necrosis factor receptor-associated periodic syndrome indicates misfolding consistent with abnormal function.
    Rebelo SL; Bainbridge SE; Amel-Kashipaz MR; Radford PM; Powell RJ; Todd I; Tighe PJ
    Arthritis Rheum; 2006 Aug; 54(8):2674-87. PubMed ID: 16871532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.